DRL launches generic Nexium 24HR capsules in US market

Dr Reddy’s Laboratories Ltd. announced the launch of the US Food and Drug Administration (FDA) approved esomeprazole magnesium delayed-release capsules USP, 20 mg, an over-the-counter (OTC) therapeutic equivalent generic version of Nexium 24HR capsules in the United States market.

Esomeprazole magnesium delayed-release capsules USP, 20 mg, is an OTC proton pump inhibitor used to treat frequent heartburn occurring two or more days a week in adults.

The combined market of Nexium 24HR capsules and private label OTC esomeprazole magnesium products had US sales of approximately $311 million for the most recent twelve months ending in May 2018 according to IRI.

Dr. Reddy’s esomeprazole magnesium delayed-release capsules USP, 20 mg is available in 14 count bottles sold in cartons of 1, 2, or 3 bottles each. Each bottle contains a complete 14-day course of treatment. Use only as directed.

Nexium is a registered trademark of AstraZeneca AB.